T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function.
T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function.
复制标题
DOI:
10.4049/jimmunol.163.9.5020
复制
发表时间:
1999-11
影响因子:
4.4
通讯作者:
Sherven P Sharma;M. Stolina;Ying Q Lin;B. Gardner;Patrice W. Miller;M. Kronenberg;S. Dubinett
中科院分区:
文献类型:
--
作者:
Sherven P Sharma;M. Stolina;Ying Q Lin;B. Gardner;Patrice W. Miller;M. Kronenberg;S. Dubinett
We have found previously that human lung cancers potently induce T lymphocyte IL-10 production in vitro. To assess the impact of enhanced T cell-derived IL-10 on antitumor immunity in vivo, we utilized transgenic mice expressing IL-10 under the control of the IL-2 promoter. We have shown previously that Lewis lung carcinoma cells (3LL) have more aggressive growth potential in IL-10 transgenic mice compared with control littermates. In this study, we show that transfer of T cells from IL-10 transgenic mice to control littermates transferred the IL-10 immunosuppressive effect and led to enhanced 3LL tumor growth. In addition to changes in T cell-mediated immunity, professional APC from IL-10 transgenic mice were found to have significantly suppressed capacity to induce MHC alloreactivity, CTL responses, and IL-12 production. Tumor Ag-pulsed dendritic cells from IL-10 transgenic mice also failed to generate antitumor reactivity. These results suggest that increased levels of T cell-derived IL-10 severely impair antitumor immunity in vivo, due to defects in both T cell and APC function.